
Louise Wang Zhiying Humphrey
Supervisory Patent Examiner (ID: 7798, Phone: (571)272-5543 , Office: P/1657 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1657, 1648 |
| Total Applications | 634 |
| Issued Applications | 269 |
| Pending Applications | 53 |
| Abandoned Applications | 317 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 887187
[patent_doc_number] => 07348004
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-03-25
[patent_title] => 'Immunoglobulin chimeric monomer-dimer hybrids'
[patent_app_type] => utility
[patent_app_number] => 11/029003
[patent_app_country] => US
[patent_app_date] => 2005-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 40
[patent_no_of_words] => 36986
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/348/07348004.pdf
[firstpage_image] =>[orig_patent_app_number] => 11029003
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/029003 | Immunoglobulin chimeric monomer-dimer hybrids | Jan 4, 2005 | Issued |
Array
(
[id] => 221153
[patent_doc_number] => 07608699
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-10-27
[patent_title] => 'Synthetic nuclear localization signal derived from lentiviral integrase and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/023996
[patent_app_country] => US
[patent_app_date] => 2004-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 34
[patent_no_of_words] => 23202
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/608/07608699.pdf
[firstpage_image] =>[orig_patent_app_number] => 11023996
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/023996 | Synthetic nuclear localization signal derived from lentiviral integrase and methods of use thereof | Dec 28, 2004 | Issued |
Array
(
[id] => 7069431
[patent_doc_number] => 20050244816
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-03
[patent_title] => 'Immunoassays, haptens, immunogens and antibodies for anti-HIV therapeutics'
[patent_app_type] => utility
[patent_app_number] => 11/019419
[patent_app_country] => US
[patent_app_date] => 2004-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 36436
[patent_no_of_claims] => 73
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0244/20050244816.pdf
[firstpage_image] =>[orig_patent_app_number] => 11019419
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/019419 | Immunoassays, haptens, immunogens and antibodies for anti-HIV therapeutics | Dec 19, 2004 | Abandoned |
Array
(
[id] => 6952130
[patent_doc_number] => 20050227224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-13
[patent_title] => 'Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions'
[patent_app_type] => utility
[patent_app_number] => 11/013786
[patent_app_country] => US
[patent_app_date] => 2004-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 12117
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20050227224.pdf
[firstpage_image] =>[orig_patent_app_number] => 11013786
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/013786 | Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions | Dec 16, 2004 | Issued |
Array
(
[id] => 6996623
[patent_doc_number] => 20050136401
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-23
[patent_title] => 'Method and device for detecting feline immunodeficiency virus'
[patent_app_type] => utility
[patent_app_number] => 11/015675
[patent_app_country] => US
[patent_app_date] => 2004-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8459
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20050136401.pdf
[firstpage_image] =>[orig_patent_app_number] => 11015675
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/015675 | Method and device for detecting feline immunodeficiency virus | Dec 16, 2004 | Issued |
Array
(
[id] => 442475
[patent_doc_number] => 07255996
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-08-14
[patent_title] => 'Compositions, methods and kits for detecting the nucleic acids of HIV-1 and HIV-2'
[patent_app_type] => utility
[patent_app_number] => 11/015605
[patent_app_country] => US
[patent_app_date] => 2004-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 23232
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 191
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/255/07255996.pdf
[firstpage_image] =>[orig_patent_app_number] => 11015605
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/015605 | Compositions, methods and kits for detecting the nucleic acids of HIV-1 and HIV-2 | Dec 15, 2004 | Issued |
Array
(
[id] => 6911869
[patent_doc_number] => 20050175627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'HIV pharmaccines'
[patent_app_type] => utility
[patent_app_number] => 11/008653
[patent_app_country] => US
[patent_app_date] => 2004-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 64
[patent_figures_cnt] => 64
[patent_no_of_words] => 19137
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20050175627.pdf
[firstpage_image] =>[orig_patent_app_number] => 11008653
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/008653 | HIV pharmaccines | Dec 8, 2004 | Abandoned |
Array
(
[id] => 7485843
[patent_doc_number] => 20110250628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-13
[patent_title] => 'Hcv replicons containing ns5b from genotype 2b'
[patent_app_type] => utility
[patent_app_number] => 10/577893
[patent_app_country] => US
[patent_app_date] => 2004-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8083
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20110250628.pdf
[firstpage_image] =>[orig_patent_app_number] => 10577893
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/577893 | HCV replicons containing NS5B from genotype 2B | Nov 2, 2004 | Issued |
Array
(
[id] => 6931119
[patent_doc_number] => 20050282154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Angiotensin-converting enzyme-2 as a receptor for the SARS coronavirus'
[patent_app_type] => utility
[patent_app_number] => 10/957880
[patent_app_country] => US
[patent_app_date] => 2004-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6337
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0282/20050282154.pdf
[firstpage_image] =>[orig_patent_app_number] => 10957880
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/957880 | Angiotensin-converting enzyme-2 as a receptor for the SARS coronavirus | Oct 4, 2004 | Abandoned |
Array
(
[id] => 82682
[patent_doc_number] => 07740858
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-22
[patent_title] => 'SARS-CoV-specific B-cell epitope and applications thereof'
[patent_app_type] => utility
[patent_app_number] => 10/945648
[patent_app_country] => US
[patent_app_date] => 2004-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4912
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/740/07740858.pdf
[firstpage_image] =>[orig_patent_app_number] => 10945648
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/945648 | SARS-CoV-specific B-cell epitope and applications thereof | Sep 20, 2004 | Issued |
Array
(
[id] => 6939735
[patent_doc_number] => 20050113298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Receptor binding peptides derived from the SARS S protein'
[patent_app_type] => utility
[patent_app_number] => 10/939113
[patent_app_country] => US
[patent_app_date] => 2004-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7206
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20050113298.pdf
[firstpage_image] =>[orig_patent_app_number] => 10939113
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/939113 | Receptor binding peptides derived from the SARS S protein | Sep 12, 2004 | Abandoned |
Array
(
[id] => 7127248
[patent_doc_number] => 20050058992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Method and device for detecting feline immunodeficiency virus'
[patent_app_type] => utility
[patent_app_number] => 10/938056
[patent_app_country] => US
[patent_app_date] => 2004-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9921
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20050058992.pdf
[firstpage_image] =>[orig_patent_app_number] => 10938056
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/938056 | Method and device for detecting feline immunodeficiency virus | Sep 9, 2004 | Issued |
Array
(
[id] => 43221
[patent_doc_number] => 07776546
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-17
[patent_title] => 'Method and device for detecting feline immunodeficiency virus'
[patent_app_type] => utility
[patent_app_number] => 10/938097
[patent_app_country] => US
[patent_app_date] => 2004-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9910
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/776/07776546.pdf
[firstpage_image] =>[orig_patent_app_number] => 10938097
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/938097 | Method and device for detecting feline immunodeficiency virus | Sep 9, 2004 | Issued |
Array
(
[id] => 6944332
[patent_doc_number] => 20050196381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-08
[patent_title] => 'Lentivirus vector-based approaches for generating an immune response to HIV in humans'
[patent_app_type] => utility
[patent_app_number] => 10/937026
[patent_app_country] => US
[patent_app_date] => 2004-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12844
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20050196381.pdf
[firstpage_image] =>[orig_patent_app_number] => 10937026
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/937026 | Lentivirus vector-based approaches for generating an immune response to HIV in humans | Sep 8, 2004 | Abandoned |
Array
(
[id] => 7033537
[patent_doc_number] => 20050032046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Cell-based method and assay for measuring the infectivity and drug sensitivity of immunodeficiency virus'
[patent_app_type] => utility
[patent_app_number] => 10/936037
[patent_app_country] => US
[patent_app_date] => 2004-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7094
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20050032046.pdf
[firstpage_image] =>[orig_patent_app_number] => 10936037
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/936037 | Cell-based method and assay for measuring the infectivity and drug sensitivity of immunodeficiency virus | Sep 7, 2004 | Abandoned |
Array
(
[id] => 6938992
[patent_doc_number] => 20050112555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Cytidine deaminase activators, deoxycytidine deaminase activators, Vif antagonists, and methods of screening for molecules thereof'
[patent_app_type] => utility
[patent_app_number] => 10/934090
[patent_app_country] => US
[patent_app_date] => 2004-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 48446
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20050112555.pdf
[firstpage_image] =>[orig_patent_app_number] => 10934090
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/934090 | Cytidine deaminase activators, deoxycytidine deaminase activators, Vif antagonists, and methods of screening for molecules thereof | Sep 2, 2004 | Abandoned |
Array
(
[id] => 390322
[patent_doc_number] => 07300918
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-11-27
[patent_title] => 'Method of producing vaccines from protein signal oligopeptides'
[patent_app_type] => utility
[patent_app_number] => 10/930300
[patent_app_country] => US
[patent_app_date] => 2004-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 13
[patent_no_of_words] => 7852
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/300/07300918.pdf
[firstpage_image] =>[orig_patent_app_number] => 10930300
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/930300 | Method of producing vaccines from protein signal oligopeptides | Aug 29, 2004 | Issued |
Array
(
[id] => 252376
[patent_doc_number] => 07579008
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-25
[patent_title] => 'Immunization with an attenuated human rotavirus'
[patent_app_type] => utility
[patent_app_number] => 10/929802
[patent_app_country] => US
[patent_app_date] => 2004-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 12766
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/579/07579008.pdf
[firstpage_image] =>[orig_patent_app_number] => 10929802
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/929802 | Immunization with an attenuated human rotavirus | Aug 29, 2004 | Issued |
Array
(
[id] => 6944362
[patent_doc_number] => 20050196411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-08
[patent_title] => 'Immunogenic HIV compositions and related methods'
[patent_app_type] => utility
[patent_app_number] => 10/928642
[patent_app_country] => US
[patent_app_date] => 2004-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13317
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20050196411.pdf
[firstpage_image] =>[orig_patent_app_number] => 10928642
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/928642 | Immunogenic HIV compositions and related methods | Aug 26, 2004 | Abandoned |
Array
(
[id] => 121110
[patent_doc_number] => 07709188
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-04
[patent_title] => 'Multi-allelic detection of SARS-associated coronavirus'
[patent_app_type] => utility
[patent_app_number] => 10/569070
[patent_app_country] => US
[patent_app_date] => 2004-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 82
[patent_figures_cnt] => 20
[patent_no_of_words] => 8669
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 337
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/709/07709188.pdf
[firstpage_image] =>[orig_patent_app_number] => 10569070
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/569070 | Multi-allelic detection of SARS-associated coronavirus | Aug 12, 2004 | Issued |